Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients

(1) Background: Social distancing rules have been widely introduced in the fight against the coronavirus disease 2019 (COVID-19) pandemic. So far, the effectiveness of these methods has not been assessed in the group of inflammatory bowel disease (IBD) patients. (2) Methods: The study included 473 p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2021-08, Vol.10 (16), p.3689
Main Authors: Łodyga, Michał, Maciejewska, Katarzyna, Eder, Piotr, Waszak, Katarzyna, Stawczyk-Eder, Kamila, Dobrowolska, Agnieszka, Kaczka, Aleksandra, Gąsiorowska, Anita, Stępień-Wrochna, Beata, Cicha, Małgorzata, Rydzewska, Grażyna
Format: Article
Language:English
Subjects:
Clinical medicine
Coronaviruses
COVID-19
Epidemics
Inflammatory bowel disease
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(1) Background: Social distancing rules have been widely introduced in the fight against the coronavirus disease 2019 (COVID-19) pandemic. So far, the effectiveness of these methods has not been assessed in the group of inflammatory bowel disease (IBD) patients. (2) Methods: The study included 473 patients with IBD who made 1180 hospital visits from 1 May to 30 September 2020. During each visit, the patients completed a five-step, progressive scale that was developed to assess the degree of social isolation. In parallel, other demographic data were collected and the concentrations of anti-severe acute respiratory coronavirus 2 (SARS-CoV-2) IgG and IgM+IgA antibodies were measured using the ELISA method. (3) Results: The study found a significant correlation between the degree of social distancing and the presence of anti-SARS-CoV-2 antibodies in the groups with the lowest degree of isolation (3 to 5). (4) Conclusions: Maintaining social distancing is an effective method for reducing the spread of SARS-CoV-2 virus among IBD patients.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm10163689